Colorado dog owners, veterinarians hopeful new drug can extend pets' lives

Colorado pet owners and veterinarians are filled with hope as a clinical trial is underway for a new drug that aims to extend the lifespan of dogs. Alex Robb, Medical Director at Goodheart Animal Health Center, explained that as dogs age, they experience metabolic inefficiencies, particularly in large breeds, which can shorten their lives. This innovative drug is designed to address these issues and potentially prolong the time dogs spend with their owners.

Goodheart Animal Health Center is actively recruiting dogs for this groundbreaking study, part of a nationwide effort. One participant, Jenna Dockweiler from Colorado, has her 12-year-old Springer Spaniel, Mason, enrolled in the trial. Dockweiler, like many pet owners, dreads the idea of losing her beloved companion, making every moment together all the more precious. Mason, a retired agility and obedience competitor, enjoys various activities, from hiking to simply lounging on the couch with his family.

Since enrolling in the STAY clinical study conducted by the San Francisco-based company Loyal, Mason has the chance to create even more memories. Dockweiler hopes not only for Mason's extended life but also for the opportunity for other pet owners to enjoy additional time with their animals. She emphasizes the importance of both the quality and quantity of their pets' lives.

The study follows a double-blind placebo format, meaning that even the participants and the medical staff are unaware of who is receiving the drug. Robb stated that once the trial is completed, the results will reveal whether the drug effectively extends dogs' lifespans. Although the exact impact on longevity is still uncertain, the prospect of extending Mason's life is a wish close to Dockweiler's heart.

Recruitment for the four-year study is ongoing, and with sufficient data, Loyal may seek conditional FDA approval by the end of the year. If successful, Dockweiler has indicated that she would consider putting her other dogs on the medication as well, underscoring the excitement and hope surrounding this significant advancement in veterinary medicine.